COMMUNIQUÉS West-GlobeNewswire

-
ProQR traite le premier patient dans l’essai STELLAR de Phase 1/2 du QR-421a pour le syndrome d’Usher de type 2
11/03/2019 -
Ossur Hf : Transactions in relation to share buyback program
11/03/2019 -
Intermountain Healthcare Launches New ‘Intermountain at Home’ Service to Enable Patients to Receive Clinical Care at Home
11/03/2019 -
Nymox to Host Investor Teleconference
11/03/2019 -
HEALTH FOUNDATION ELECTS OFFICERS TO BOARD OF DIRECTORS
11/03/2019 -
Xbrane Biopharma informs that trading in subscription rights and interim shares is delayed and will be initiated 12 March 2019
11/03/2019 -
Lumere Lands on Crain’s “2019 Best Places to Work in Chicago” List
11/03/2019 -
HOOPP 2018 Results: Delivering on the pension promise to our members
11/03/2019 -
ActivX Biosciences reports key findings that could impact the use of clinically approved CDK4/6 inhibitors in the treatment of cancer patients
11/03/2019 -
Resverlogix Announces Participation at Prominent Industry and Investor Conferences
11/03/2019 -
5 Influential Companies In CBD-Infused Beverages
11/03/2019 -
Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada
11/03/2019 -
Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal
11/03/2019 -
CORRECTION - Exactus Announces Agricultural Diversification with Entry Into 200 Acre Farming Project for 2019 Grow Season – Promotion of Emiliano Aloi as President
11/03/2019 -
Precipio CEO Issues Shareholder Update Letter
11/03/2019 -
Share buy-back week 10/2019
11/03/2019 -
Novo Nordisk A/S - Share repurchase programme
11/03/2019 -
Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University
11/03/2019 -
Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting
11/03/2019
Pages